•Inflammation-anchored injectable hydrogel integrating pathological nitric oxide scavenging and on-demand drug release for localized inflammatory bowel disease therapy
•Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies
•Infliximab Serum Level Assessment After Switching from Intravenous to Subcutaneous Administration: The ISLASIS Study
•Organizing pneumonia in Crohn's disease: a case report and literature review
•Design and discovery of highly potent lysine 27 of histone H3 (H3K27) demethylase inhibitors for the treatment of inflammatory bowel disease
